Comparison of lenograstim and filgrastim: effects on blood cell recovery after high-dose chemotherapy and autologous peripheral blood stem cell transplantation.

Hüttmann, A; Schirsafi, K; Seeber, S; Bojko, P

Hüttmann, A; Schirsafi, K; Seeber, S; Bojko, P.

Affiliation

Hüttmann A; Department of Hematology, Center for Internal Medicine, West German Cancer Center, Universitätsklinikum Essen, Hufelandstrasse 55, 45122 Essen, Germany. andreas.huettmann@uni-essen.de

J Cancer Res Clin Oncol ; 131(3): 152-6, 2005 Mar.

Article in En | MEDLINE | ID: mdl-15583936

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Granulocyte Colony-Stimulating Factor/therapeutic use; Peripheral Blood Stem Cell Transplantation/adverse effects; Recombinant Proteins/therapeutic use; Adjuvants, Immunologic/therapeutic use; Adult; Anti-Bacterial Agents/administration & dosage; Drug Administration Schedule; Female; Filgrastim; Humans; Length of Stay; Lenograstim; Leukocytes/drug effects; Male; Middle Aged; Platelet Transfusion; Time Factors; Transplantation, Autologous; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Antineoplastic Combined Chemotherapy Protocols / Granulocyte Colony-Stimulating Factor / Peripheral Blood Stem Cell Transplantation Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Cancer Res Clin Oncol Year: 2005 Document type: Article Affiliation country: Germany Country of publication: Germany

Search on Google

Add to My VHL

XML

PubMed Links